Partnership launched under MTEA to evaluate the potential of Vect-Horus technology to deliver siRNAs into the CNSAssessment ...
Lundbeck posted quarterly revenue of 6.09 billion Danish kroner ($960 million), an increase of 10% on a year ago, and adjusted EBITDA of 1.61 billion kroner, up 40%. Adjusted earnings per share (EPS) ...
Presentations Highlight Potential Benefits of Therapies Incorporating J-Brain Cargo®, JCR’s Proprietary, Blood-Brain Barrier-Penetrating Technology -HYOGO, Japan--(BUSINESS WIRE)--JCR Pharmaceuticals ...
Emcure Pharma's Q3 FY26 net profit rose 48% on strong domestic and international growth, as the company eyes entry into India ...
Service ensures that clinicians are properly qualified, consistently trained and monitored throughout the life of a trialMAIDENHEAD, England--(BUSINESS WIRE)--RWS (RWS.L), a global AI solutions ...
Cycle Group Holdings Limited ("Cycle") is delighted to announce it has completed the acquisition of NASDAQ-listed Applied Therapeutics, Inc. (NASDAQ: APLT; "Applied"), a clinical-stage ...
Qelbree-led growth, Sage acquisition synergies, and <4x forward P/S support ~25% upside into 2026. Click for more on SUPN ...
Cognision today unveiled Cognision360(TM), a groundbreaking web-based platform that consolidates multiple neurobiomarker data streams into a single, standardized system--addressing one of the ...
TONMYA demonstrated significant reduction in fibromyalgia pain compared with placebo in the Phase 3 RESILIENT studyUnique sublingual formulation ...
Danish CNS company Lundbeck announced six-month data from the 12-month, real-world INFUSE study, evaluating the effectiveness ...
Exxel Pharma is eyeing a listing on the NYSE American to fund human trials for a drug class that has previously struggled to ...
Mumbai: Global pharma major Lupin Limited has announced the launch of Dasatinib Tablets in strengths of 20 mg, 50 mg, 70 mg, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results